Metabolism and Target Organ Damage (M&TOD) is an international, peer-reviewed, open-access interdisciplinary journal that provides an online platform for the publication of clinical, basic, and translational studies. It covers cardio-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension, and hyperuricemia in all age groups. Of note, this journal will emphasize the role of these metabolic disorders as either effectors/amplifiers or consequences of the development and progression of injuries to target organs including but not limited to the cardiovascular system, the liver, kidneys, and the pancreas. Specific applications in metabolic disorders are as follows: history of medicine, drug metabolism; epidemiology, prevention, natural history, genetics, cell, and molecular biology, pathobiochemistry, physiopathology, anatomic pathology, clinical chemistry, pharmaceutical chemistry, pharmacology, psychology, psychiatry, statistics, and immunology.
From a clinical point of view, the journal covers aspects of biomarkers, diagnosis, prognosis and all types of innovative management strategies including cognitive-behavioral approaches and randomized controlled trials of innovative drug schedules of metabolic disorders. M&TOD welcomes publishing research to promote the development of animal-free models of studies including cell cultures, artificial intelligence and others.
M&TOD particularly welcomes studies of translational value of ranging from basic science to clinical applications. Our journal is interested in evaluating submissions pertaining to all areas of public health including health policy; health economics, internal medicine and its sub-specialties, such as cardiology, endocrinology, hepato-gastroenterology, nephrology, oncology, general surgery and its branches such as bariatric, endocrine, vascular, metabolic, oncological surgery.
M&TOD accepts submissions of the following editorial categories: Original Article, Review, Commentary, Mini-Review, Systematic Review, Meta-analysis, Editorial, Perspective, Opinion, Communication, Letter to Editor and Research Highlight.
The main areas of interest include the following:
Artificial intelligence and cardio-metabolic disorders
Atrial fibrillation
Autoimmunity
Bariatric surgery
Bile Acids
Cachexia
Cancer and metabolic disorders
Cancerogenesis
Cellular biology and molecular pathways of insulin resistance
Cholestasis
Chronic kidney injury owing to cardio-metabolic disorders
Cytokines, adipokines and hepatokines
Cognitive-Behavioral approach to cardio-metabolic disorders
Coronary artery disease
C-Reactive Protein
Diabetes phenotypes
Diabetic foot ulcer
Diabetic nephropathy
Diabetic retinopathy
Disorders of cardiac valves owing tocardio- metabolic disorders
Disorders of iron metabolism
Drug-induced cardio-metabolic disorders
Drug metabolism
Endoplasmic reticulum stress and cardio-metabolic diseases
Endothelial dysfunction
Energy homeostasis and cardio-metabolic disorders
Extra-hepatic manifestations of NAFLD
Failure to thrive
Fatty pancreas
Genetic basis of cardio-metabolic disorders
Geriatrics and cardio-metabolic disorders
Gut microbiota, virobiota, mycobiota an cardio-metabolic disorders
Health economics and cardio-metabolic disorders
Heart failure
Hereditary hemochromatosis
History of cardio-metabolic disorders
Hormone replacement therapy and cardio-metabolic disorders
Hypertriglyceridemia
Hypetrigliceridemia
Hyperuricemia
Imaging of cardio-metabolic disorders
Immuno-metabolism
Infections and cardio-metabolic disorders
Insulin sensitizers
Lifestyle and metabolism
Lysosomal storage disease
MAFLD-NAFLD debate
Mechanisms of cell damage in cardio-metabolic disorders
Metabolic bone disease
Metabolic derangements in acute and chronic bacterial and viral infections
Metabolic surgery
Metabolic actions of Intra-gastric balloon devices
Metabolic disorders in liver cirrhosis
Metabolic disorders in pregnancy
Metabolic disorders in rheumatology
Metabolic disorders in the transplanted patients
Metabolically healthy and unhealthy obesity
Metabolically obese, normal weight
Metabolic syndrome
Metabolism and longevity
Metabolomics
Metaflammation
Migration and cardio-metabolic disorders
Mitochondrial pathobiology and cardio-metabolic disorders
Myocardial infarction owing to metabolic disorders
NAFLD secondary to endocrine disorders
Neonatal metabolic disorders
Neurodegenerative disorders and metabolism
Novel anti-diabetic drug agents
Novel cholesterol-lowering approaches
Nuclear Receptors
Nutriceuticals
Obesity phenotypes: android vs. gynoid
Occupational medicine and cardio-metabolic disorders
Oxidative stress and cardio-metabolic disorders
Pathobiology of stress and cardio-metabolic disorders
Pathology of metabolic disorders: from anatomic pathology to histo-cytology
Pediatric cardio-metabolic disorders
Pharmacotherapy of cardio-metabolic disorders
Physical exercise as a treatment of cardio-metabolic disorders
Physiology of metabolism
Prevention of cardio-metabolic disorders
Psychology of cardio-metabolic disorders
Rare metabolic diseases
Research gaps in cardio-metabolic disorders
Sarcopenia and cardio-metabolic disorders
Screening of cardio-metabolic disorders
Secondary arterial hypertension
Sex differences in cardio-metabolic disorders
Smoking and cardio-metabolic disorders
Statins
Steatogenesis
Stroke
Systemic inflammation, subclinical
Telomere attrition
Thyromimetics and cardio-metabolic disorders
Thrombosis in metabolic disorders
Variable topography of atherosclerosis: coronary vs. cerebral vs. visceral vs. peripheral
Vascular surgery in dysmetabolic indivduals
Weight loss and ageing